ethinyl estradiol-norgestrel combination has been researched along with Heavy Menstrual Bleeding in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chowdary, GV; Murthy, JM; Narayanan, TJ | 1 |
Khatree, MH; Titiz, H | 1 |
Buckshee, K; Sharma, JB; Sharma, S | 1 |
Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
Scheinfeld, N | 1 |
El-Nashar, SA; Sayed, GH; Shaaban, MM; Zakherah, MS | 1 |
4 trial(s) available for ethinyl estradiol-norgestrel combination and Heavy Menstrual Bleeding
Article | Year |
---|---|
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Treatment Failure; Treatment Outcome | 2011 |
4 other study(ies) available for ethinyl estradiol-norgestrel combination and Heavy Menstrual Bleeding
Article | Year |
---|---|
Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Intrauterine Devices, Medicated; Lateral Sinus Thrombosis; Levonorgestrel; Menorrhagia | 2005 |
Medical treatment of a uterine arteriovenous malformation.
Topics: Arteriovenous Malformations; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menorrhagia; Middle Aged; Ultrasonography, Doppler, Color; Uterus | 1999 |
Puberty menorrhagia due to Bernard Soulier syndrome and its successful treatment by 'Ovral' hormonal tablets.
Topics: Adult; Bernard-Soulier Syndrome; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menorrhagia; Norgestrel; Puberty | 1991 |
Menorrhagia and severe menstrual pain related to the use of adalimumab in a psoriatic.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Contraceptives, Oral, Combined; Drug Combinations; Drug Labeling; Dysmenorrhea; Etanercept; Ethinyl Estradiol; Female; Humans; Immunoglobulin G; Immunologic Factors; Levonorgestrel; Menorrhagia; Obesity, Morbid; Product Surveillance, Postmarketing; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; United Kingdom; United States | 2008 |